Who is moving to which position
Resolved 21 April 2026Incoming appointee
2 itemsDeparting officer
1 item“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Joe Harlan (ジョー・ハーラン) will cease to serve as a director following a request from Joe Harlan (ジョー・ハーラン) for health reasons.
Will not remain on the Board of Directors
Joe Harlan (ジョー・ハーラン) will cease to serve as a director following a request from Joe Harlan (ジョー・ハーラン) for health reasons.
| Item | Details |
|---|---|
| Resolution date | 21 April 2026 |
| Scheduled Appointment Date | After the annual general meeting of shareholders scheduled for June 2026 (the specific scheduled date is Not disclosed). The election of the director candidates is scheduled to be submitted to the annual general meeting of shareholders. |
| Date of departure | 21 April 2026 |
| Name of appointee | Ilham Kadri, Chino Masahiko (知野雅彦) |
| Appointee's new position | Outside Director (Nomination, Audit and Compensation Committees), Outside Director (Chair of the Audit Committee) |
| Appointee's previous position | Current Director of A.O. Smith (US) / Director of L'Oréal (France), Current Co-Chairman of KPMG Japan |
| Name of departing officer | Joe Harlan (ジョー・ハーラン) |
| Former position of departing officer | Directors |
| New position of departing officer | Retirement |
| Reason for departure | Joe Harlan (ジョー・ハーラン) will cease to serve as a director following a request from Joe Harlan (ジョー・ハーラン) for health reasons. |
| Whether the incumbent will remain in office | Will not remain on the Board of Directors |
| Reason for change | Joe Harlan (ジョー・ハーラン) will cease to serve as a director following a request from Joe Harlan (ジョー・ハーラン) for health reasons. |
| Number of directors after the change | 11 directors (including 8 outside directors) |
| Subject to Approval by the General Meeting of Shareholders | Required. A proposal for the election of the director candidates is scheduled to be submitted at the annual general meeting of shareholders scheduled for June 2026 (the scheduled date is Not disclosed). |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Request by the individual for health reasons